Pages that link to "Q39725736"

The following pages link to Structure-activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides (Q39725736):

Displaying 32 items.

• Targeting Toll-like receptors with small molecule agents (Q26992220) (← links)
• Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen (Q30388683) (← links)
• Human Toll-like receptor 8-selective agonistic activities in 1-alkyl-1H-benzimidazol-2-amines (Q34164851) (← links)
• Determinants of activity at human Toll-like receptors 7 and 8: quantitative structure-activity relationship (QSAR) of diverse heterocyclic scaffolds (Q34313816) (← links)
• Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines. (Q34394100) (← links)
• A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors (Q35166960) (← links)
• Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide (Q35886752) (← links)
• Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity. (Q36147897) (← links)
• Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolines (Q36625137) (← links)
• Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants. (Q37352073) (← links)
• Modern subunit vaccines: development, components, and research opportunities (Q38073752) (← links)
• Nanovaccines and their mode of action. (Q38102471) (← links)
• TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors (Q38132733) (← links)
• Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact (Q38279548) (← links)
• Strategies for designing synthetic immune agonists (Q38841677) (← links)
• Controlling the origins of inflammation with a photoactive lipopeptide immunopotentiator. (Q39026309) (← links)
• Novel glycolipid TLR2 ligands of the type Pam2Cys-α-Gal: Synthesis and biological properties (Q39368205) (← links)
• Structure–Activity Relationships in Toll-Like Receptor 2-Agonists Leading to Simplified Monoacyl Lipopeptides (Q39539750) (← links)
• Potent adjuvantic activity of a CCR1-agonistic bis-quinoline (Q40077881) (← links)
• Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines (Q40998064) (← links)
• Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist. (Q41388766) (← links)
• Toward self-adjuvanting subunit vaccines: model peptide and protein antigens incorporating covalently bound toll-like receptor-7 agonistic imidazoquinolines (Q42021841) (← links)
• Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides. (Q42050375) (← links)
• Exquisite selectivity for human toll-like receptor 8 in substituted furo[2,3-c]quinolines. (Q42096062) (← links)
• Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic γ-glutamyldiaminopimelic acid derivatives (Q42716723) (← links)
• Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics (Q47590580) (← links)
• Glycerol as Precursor of Organoselanyl and Organotellanyl Alkynes. (Q50206650) (← links)
• Syntheses of Human TLR8-Specific Small-Molecule Agonists (Q51415073) (← links)
• Transcriptomal signatures of vaccine adjuvants and accessory immunostimulation of sentinel cells by toll-like receptor 2/6 agonists (Q88933795) (← links)
• Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity (Q88956155) (← links)
• Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines (Q89388768) (← links)
• Development of N-Acetylated Dipalmitoyl-S-Glyceryl Cysteine Analogs as Efficient TLR2/TLR6 Agonists (Q90383914) (← links)